Nexalin Technology, Inc. – NASDAQ:NXLIW

Nexalin Technology stock price today

$0.025
-0.32
-92.94%
Financial Health
0
1
2
3
4
5
6
7
8
9

Nexalin Technology stock price monthly change

+80.78%
month

Nexalin Technology stock price quarterly change

+80.78%
quarter

Nexalin Technology stock price yearly change

+3877.27%
year

Nexalin Technology key metrics

Market Cap
 46.49M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.66
Revenue
 158.86K
EBITDA
 -5.94M
Income
 -4.94M
Revenue Q/Q
 157.43%
Revenue Y/Y
 -84.55%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 -3740.81%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Nexalin Technology stock price history

Nexalin Technology stock forecast

Nexalin Technology financial statements

Profit Margin

Nexalin Technology, Inc. (NASDAQ:NXLIW): Profit margin
Jun 2023 35.54K -822.43K -2314.12%
Sep 2023 24.11K -2.29M -9526.77%
Dec 2023 20.53K -780.66K -3801.47%
Mar 2024 78.67K -1.04M -1323.43%
NXLIW income statement history

Debt to Assets

Nexalin Technology, Inc. (NASDAQ:NXLIW): Debt to assets
Jun 2023 5175621 1.18M 22.85%
Sep 2023 4433767 1.19M 27%
Dec 2023 3631916 425.28K 11.71%
Mar 2024 2834210 507.22K 17.9%
NXLIW balance sheet history

Cash Flow

Nexalin Technology, Inc. (NASDAQ:NXLIW): Cash Flow
Jun 2023 -815.61K 872.37K 0
Sep 2023 -701.09K 830.76K 0
Dec 2023 -1.00M 1.22M 0
Mar 2024 -763.28K 729.31K 0
NXLIW cash flow history

Nexalin Technology alternative data

Nexalin Technology
Employees

Nexalin Technology, Inc. (NASDAQ:NXLIW): Employee count
Aug 2023 3
Sep 2023 3
Oct 2023 3
Nov 2023 3
Dec 2023 3
Jan 2024 6
Feb 2024 6
Mar 2024 6
Apr 2024 6
May 2024 6
Jun 2024 6
Jul 2024 6

Nexalin Technology other data

Frequently Asked Questions (FAQ)

  • What's the price of Nexalin Technology stock today?

    One share of Nexalin Technology stock can currently be purchased for approximately $0.02.

  • When is Nexalin Technology's next earnings date?

    Unfortunately, Nexalin Technology's (NXLIW) next earnings date is currently unknown.

  • Does Nexalin Technology pay dividends?

    No, Nexalin Technology does not pay dividends.

  • How much money does Nexalin Technology make?

    Nexalin Technology has a market capitalization of 46.49M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 91.62% to 110.75K US dollars.

  • What is Nexalin Technology's stock symbol?

    Nexalin Technology, Inc. is traded on the NASDAQ under the ticker symbol "NXLIW".

  • What is Nexalin Technology's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Nexalin Technology?

    Shares of Nexalin Technology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Nexalin Technology have?

    As Jul 2024, Nexalin Technology employs 6 workers.

  • What is Nexalin Technology's official website?

    The official website for Nexalin Technology is nexalin.com.

  • Where are Nexalin Technology's headquarters?

    Nexalin Technology is headquartered at 1776 Yorktown, Houston, TX.

  • How can i contact Nexalin Technology?

    Nexalin Technology's mailing address is 1776 Yorktown, Houston, TX and company can be reached via phone at +7 136601100.

Nexalin Technology company profile:

Nexalin Technology, Inc.

nexalin.com
Exchange:

NASDAQ

Full time employees:

6

Industry:

Medical - Devices

Sector:

Healthcare

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.

+7 136601100
1776 Yorktown
Houston, TX 77056

CIK: 0001527352
ISIN: US65345B1109
CUSIP: 65345B110